Top Markets
#1 Velvet Velvet +31.64%
#2 Prom Prom +31.47%
#3 QuantixAI QuantixAI +31.15%
#4 MowCat MowCat +28.48%
#5 Tutorial Tutorial +24.58%
#6 UnifAI Network UnifAI Network +24.16%
#7 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +21.99%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +20.82%
#9 MarsCoin MarsCoin +18.70%
#10 Versatize Coin Versatize Coin +16.65%
Coin of the day
Velvet Velvet
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Hisse Senetlerindeki Sıralama #20515
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Hisse Fiyatı
$20.38
Piyasa Değeri
$129.09M
Değişim (1 gün)
-0.82%
Değişim (1 yıl)
80.91%
Ülke
PL
Ticaret Captor Therapeutics Spolka Akcyjna (CTX)

Kategori

Healthcare
Captor Therapeutics Spolka Akcyjna (CTX) için kazanç
2026 itibarıyla kazanç TTM: 0
Captor Therapeutics Spolka Akcyjna şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Captor Therapeutics Spolka Akcyjna için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH